2023 Form 5500 filing — Value Drug Company Welfare Benefit Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240717113157NAL0008551186001) for Value Drug Company Welfare Benefit Plan, reported by Value Drug Company under EIN 23-1179140 and plan number 501. It reports 229 participants. Attached schedules in the loaded dataset include Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240717113157NAL0008551186001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Value Drug Company
- EIN
- 23-1179140
- Plan number
- 501
- Location
- Duncansville, PA
- Participants
- 229
- Schedules available
- Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
This 2023 filing is loaded, but detailed Schedule H/I financial figures are not present for it in the current loaded dataset. Participant counts and filing identity above are reported; asset and contribution detail comes from the financial schedules where filed.
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Optum | MEDICAL TPA | $98,169 | not reported in the loaded dataset |
| The Benecon Group, LLC | BROKER | $25,152 | not reported in the loaded dataset |